Evidence map›Paper›PMID 28188587›Full record

ReviewCurrent psychiatry reports2017

Circadian Rhythms and Substance Abuse: Chronobiological Considerations for the Treatment of Addiction.

Ian C Webb

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Dopamine systems and biological rhythms: Let's get a move on.Frontiers in integrative neuroscience · 2022
    Review
  10. Review
  11. Article
  12. Time-of-day as a critical biological variable.Neuroscience and biobehavioral reviews · 2021
    Review
  13. Review
  14. The Brain's Reward System in Health and Disease.Advances in experimental medicine and biology · 2021
    Article
  15. Article
  16. Sobriety and Satiety: Is NAD+ the Answer?Antioxidants (Basel, Switzerland) · 2020
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ian C WebbDepartment of Neurobiology and Anatomical Sciences, University of Mississippi Medical Center, 2500 N. State St., Jackson, MS, 39216, USA. iwebb@umc.edu.
University of Mississippi Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reward-related learning, including that associated with drugs of abuse, is largely mediated by the dopaminergic mesolimbic pathway. Mesolimbic neurophysiology and motivated behavior, in turn, are modulated by the circadian timing system which generates ∼24-h rhythms in cellular activity. Both drug taking and seeking and mesolimbic dopaminergic neurotransmission can vary widely over the day. Moreover, circadian clock genes are expressed in ventral tegmental area dopaminergic cells and in mesolimbic target regions where they can directly modulate reward-related neurophysiology and behavior. There also exists a reciprocal influence between drug taking and circadian timing as the administration of drugs of abuse can alter behavioral rhythms and circadian clock gene expression in mesocorticolimbic structures. These interactions suggest that manipulations of the circadian timing system may have some utility in the treatment of substance abuse disorders. Here, the literature on bidirectional interactions between the circadian timing system and drug taking is briefly reviewed, and potential chronotherapeutic considerations for the treatment of addiction are discussed.

Indexed as

AnimalsBehavior, AddictiveChronotherapyCircadian RhythmCLOCK ProteinsDopamineGene Expression RegulationHumansLimbic SystemMesencephalonMotivationNerve NetPrefrontal CortexRecurrenceRewardRisk FactorsCLOCK protein, humanCLOCK ProteinsDopamineAddictionChronotherapyCircadianDiurnalReward

Identifiers

PMID28188587
OpenAlexW2586236473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.